| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.36 | 0.03 |